Due to lack of better therapeutic options, colistin use for extensively drug-resistant Gram-negative organisms was revived in the past two decades, including in patients in intensive-care units (ICU). There are multiple knowledge gaps pertaining to the clinical use and utility of colistin in critically-ill patients, but due to lack of options, it is used in these high risk patients. In this chapter, we critically review the various topics pertaining to colistin use in critically-ill patients, while highlighting the (lack of) controlled evidence supporting common current practices pertaining to colistin use by clinicians.
CITATION STYLE
Marchaim, D., Kaye, D., & Kaye, K. S. (2019). Use of Colistin in Critically Ill Patients. In Advances in Experimental Medicine and Biology (Vol. 1145, pp. 155–179). Springer New York LLC. https://doi.org/10.1007/978-3-030-16373-0_12
Mendeley helps you to discover research relevant for your work.